Please confirm you are human (Sign Up for free to never see this)
← Back to Search
RSPO2 Enhances Canonical Wnt Signaling To Confer Stemness-Associated Traits To Susceptible Pancreatic Cancer Cells.
Matthias Ilmer, Alejandro Recio Boiles, I. Regel, K. Yokoi, C. Michalski, I. Wistuba, J. Rodríguez, E. Alt, J. Vykoukal
Published 2015 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Cancer stem cells (CSC) present a formidable clinical challenge by escaping therapeutic intervention and seeding tumors through processes that remain incompletely understood. Here, we describe small subpopulations of pancreatic cancer cells with high intrinsic Wnt activity (Wnt(high)) that possess properties indicative of CSCs, including drug resistance and tumor-initiating capacity, whereas cell populations with negligible Wnt activity (Wnt(low)) preferentially express markers of differentiation. Spontaneous response to extrinsic Wnt signals induces signaling networks comprising ERK1/2 and epithelial-mesenchymal transition that subsequently confer cancer stemness traits to susceptible cells. Wnt enhancer R-Spondin 2 (RSPO2) seems to play a prominent upstream role in regulating this interplay. In this context, Wnt(high) cells were more likely to give rise to Wnt(high) progeny, tended to be more metastatic, and revealed higher levels of RSPO2 expression. Our studies reveal adaptive aspects of pancreatic cancer stemness arising from driver populations of CSCs that misappropriate functional and responsive elements of archetypical self-renewal pathways. Blocking such stemness-promoting pathways in conjunction with established chemotherapy could provide means to disrupt dynamic CSC process and present novel therapeutic targets and strategies.
This paper references
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.
P. Hermann (2007)
Wnt/β-Catenin and MAPK Signaling: Allies and Enemies in Different Battlefields
D. Guardavaccaro (2012)
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.
Y. Zhang (2013)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
A. Gurney (2012)
Adult mammalian stem cells: the role of Wnt, Lgr5 and R‐spondins
Jurian Schuijers (2012)
Molecular Profiling of Direct Xenograft Tumors Established from Human Pancreatic Adenocarcinoma After Neoadjuvant Therapy
M. Kim (2011)
Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity
Zhaoqiu Wu (2012)
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.
Yifang Hu (2009)
Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis
L. Zhang (2010)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
S. Liu (2014)
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A Mani (2008)
Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
Marina Pasca di Magliano (2007)
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.
C. Scheel (2012)
Canonical wnt signaling is required for pancreatic carcinogenesis.
Y. Zhang (2013)
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
L. Vermeulen (2010)
Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway
C. Fuerer (2010)
Microenvironmental regulation of stem cells in intestinal homeostasis and cancer
J. P. Medema (2011)
Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.
K. Yokoi (2005)
A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
J. Caramel (2013)
Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.
J. Lu (2013)
Colony-forming cells in the adult mouse pancreas are expandable in Matrigel and form endocrine/acinar colonies in laminin hydrogel
Liang Jin (2013)
Wnt/β-Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAFV600E in Human Melanoma
T. Biechele (2012)
RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
Changjie Wu (2014)
The epigenetics of epithelial-mesenchymal plasticity in cancer
W. L. Tam (2013)
Ras Stabilization Through Aberrant Activation of Wnt/β-Catenin Signaling Promotes Intestinal Tumorigenesis
Woo-Jeong Jeong (2012)
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
J. Qin (2012)
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
B. Chen (2009)
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
C. Scheel (2011)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
U. Wellner (2009)
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
N. Takebe (2011)
Cancer stem cells: in the line of fire.
M. Alison (2012)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
Christine L Chaffer (2013)
Wnt/β-catenin signaling in cancer stemness and malignant behavior
R. Fodde (2007)
WNT7B mediates autocrine Wnt/β-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma
Michael D. Arensman (2014)
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
B. Hennessy (2010)
Wnt Signaling Regulates the Invasion Capacity of Human Mesenchymal Stem Cells
P. Neth (2006)
To differentiate or not — routes towards metastasis
T. Brabletz (2012)
Cancer stem cells in solid tumors.
L. Ailles (2007)
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.
J. Domingo-Doménech (2012)
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
M. Huch (2013)
Towards a knowledge-based Human Protein Atlas
M. Uhlén (2010)
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
M. Gerlinger (2012)
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.
S. Cairo (2008)
A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics*
M. Uhlén (2005)
This paper is referenced by
Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma
Matthias Ilmer (2015)
ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling.
L. Yan (2016)
Neurokinin-1 receptor as a therapeutic target in hepatoblastoma
A. Garnier (2016)
TRAF3IP2, a novel therapeutic target in glioblastoma multiforme
E. Alt (2018)
A simple open-source method for highly multiplexed imaging of single cells in tissues and tumours
Jia-Ren Lin (2017)
Comparative secretome analysis of normal prostate and prostate cancer cell models
Euan Johnstone (2017)
Differential effects of spinal motor neuron-derived and skeletal muscle-derived Rspo2 on acetylcholine receptor clustering at the neuromuscular junction
J. Li (2018)
SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.
Y. Li (2017)
Genome-wide analysis of Chongqing native intersexual goats using next-generation sequencing
G. E (2019)
Unveiling the Potential of Repurposing FDA-Approved Drugs in Pancreatic Cancer
Matthias Ilmer (2018)
Chemoresistance in pancreatic cancer: Emerging concepts.
Manu Gnanamony (2017)
Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver Metastases
Neda Jabbari (2020)
RSPO2 enriches LGR5(+) spheroid colon cancer stem cells and promotes its metastasis by epithelial-mesenchymal transition.
Shi Zhang (2016)
Pancreatic Ductal Adenocarcinoma Stem Cells
U. Aghamaliyev (2015)
Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer
Michael D. Arensman (2015)
Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality
T. Donahue (2016)
Identification of DPY19L3 as the C-mannosyltransferase of R-spondin1 in human cells
Y. Niwa (2016)
R-spondin family members as novel biomarkers and prognostic factors in lung cancer
L. Wu (2019)
RSPO3 promotes the aggressiveness of bladder cancer via Wnt/&bgr;-catenin and Hedgehog signaling pathways
Zhao-hui Chen (2019)
A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma
T. Tammela (2017)
Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
B. Renz (2017)
CTCF-mediated chromatin looping in EGR2 regulation and SUZ12 recruitment critical for peripheral myelination and repair
Jincheng Wang (2020)
Inflammation-Related Pancreatic Carcinogenesis: Mechanisms and Clinical Potentials in Advances
Juan-juan Dai (2017)
Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma
Yang Hua (2017)
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
Asunción Espinosa-Sánchez (2020)
Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
A. Garnier (2015)
Therapeutic Innovations for Targeting Hepatoblastoma.
A. Garnier (2016)
Wnt Signaling and Drug Resistance in Cancer
Z. Zhong (2020)
R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cells
S. Liu (2018)
Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells
M. Ilmer (2016)
Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma
Zhuan Lv (2017)
Pathobiology of pancreatic cancer: implications on therapy
I. Regel (2016)See more